200 related articles for article (PubMed ID: 16143789)
61. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
Meigooni AS; Hayes JL; Zhang H; Sowards K
Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
[TBL] [Abstract][Full Text] [Related]
62. Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist.
Lessard E; Kwa SL; Pickett B; Roach M; Pouliot J
Med Phys; 2006 Aug; 33(8):2773-82. PubMed ID: 16964853
[TBL] [Abstract][Full Text] [Related]
63. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
64. Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants.
Dawson JE; Wu T; Roy T; Gu JY; Kim H
Radiother Oncol; 1994 Sep; 32(3):268-70. PubMed ID: 7816946
[TBL] [Abstract][Full Text] [Related]
65. Phantom size in brachytherapy source dosimetric studies.
Pérez-Calatayud J; Granero D; Ballester F
Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
[TBL] [Abstract][Full Text] [Related]
66. Monte Carlo aided design of an improved well-type ionization chamber for low energy brachytherapy sources.
Bohm TD; Micka JA; DeWerd LA
Med Phys; 2007 Apr; 34(4):1274-85. PubMed ID: 17500459
[TBL] [Abstract][Full Text] [Related]
67. Spectroscopic output of 125I and 103Pd low dose rate brachytherapy sources.
Usher-Moga J; Beach SM; DeWerd LA
Med Phys; 2009 Jan; 36(1):270-8. PubMed ID: 19235395
[TBL] [Abstract][Full Text] [Related]
68. A radiobiological investigation on dose and dose rate for permanent implant brachytherapy of breast using 125I or 103Pd sources.
Baltas D; Lymperopoulou G; Löffler E; Mavroidis P
Med Phys; 2010 Jun; 37(6):2572-86. PubMed ID: 20632569
[TBL] [Abstract][Full Text] [Related]
69. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
70. Two-dimensional dosimetry in the near field of the model 200 103Pd source for interstitial brachytherapy implants using a thermoluminescent sheet.
Iwata K; Yue NJ; Nath R
Phys Med Biol; 2004 Sep; 49(17):4049-63. PubMed ID: 15470922
[TBL] [Abstract][Full Text] [Related]
71. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
72. Fitting and benchmarking of dosimetry data for new brachytherapy sources.
Furhang EE; Wallace RE
Med Phys; 2000 Oct; 27(10):2302-6. PubMed ID: 11099198
[TBL] [Abstract][Full Text] [Related]
73. Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.
Todor DA; Barani IJ; Lin PS; Anscher MS
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):297-304. PubMed ID: 21536392
[TBL] [Abstract][Full Text] [Related]
74. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
75. More accurate fitting of 125I and 103Pd radial dose functions.
Taylor RE; Rogers DW
Med Phys; 2008 Sep; 35(9):4242-50. PubMed ID: 18841874
[TBL] [Abstract][Full Text] [Related]
76. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
77. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
[TBL] [Abstract][Full Text] [Related]
78. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
79. Validation of GPUMCD for low-energy brachytherapy seed dosimetry.
Hissoiny S; Ozell B; Després P; Carrier JF
Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010
[TBL] [Abstract][Full Text] [Related]
80. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
Chen Z; Nath R
Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
